Azenta to sell B Medical Systems to Thelema for $63 million
Azenta's subsidiary Azenta Germany GmbH signed a definitive agreement on December 23, 2025 to sell B Medical Systems S.À R.L. to Thelema S.À R.L. for $63 million, with closing expected on or before March 31, 2026. The buyer's completion depends on securing final residual financing, and the filing states there is no assurance that condition will be met. The transaction is with a related party, since Thelema's majority owner is Luc Provost, Azenta's Vice President and CEO of B Medical.
Key points
- Purchase price is $63 million: $9 million deposited with Azenta Germany GmbH and $54 million due on or before March 31, 2026.
- Thelema's financing for the acquisition is a condition to completion; if not satisfied by March 31, 2026, either party may terminate.
- If terminated for the financing condition, Azenta Germany GmbH will keep $5 million of the deposit as a break-up fee.
- Related party: Luc Provost, Azenta Vice President and CEO of B Medical, is Thelema's majority owner; the filing says terms were negotiated at arm's length after a competitive auction.
The filing
Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 29, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.